I have been having a discussion with others about the level of dollars allocated to lung cancer research to support research and related programs. I knew that lung cancer dollars were small in comparison, but I could not verify them.
This same site, however, takes one to the NIH, etc funding summary. For those interested, funding for FY 2010 is proposed as follows: (1) brain cancer--$205 million; (2) breast--$769 million; (3) lung--$179 million; (4) cancer (appears to be generic or possibly total--can't really tell)--$6.0 billion; (5) colo-rectal--$290 million; (6) prostate--$309 million; (7) liver--$93 million; (8) cervical--$73 million; (9) ovarian--$102 million; and (10) uterine--$17 million.
Unfortunately, it is a bit difficult to get a grand total to each type of program because numerous other programs are being funded, which may (or may not) support cancer research and related programs.
No matter how you cut it, however, lung cancer funding appears low relative to other programs and level of incidence and mortalilty. I think a reasoned response is to formally request a reply from NIH, DOD, and NCI as to why this is the case.
Jim




Add to the discussion